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Overview
In 1998, the Institute of Medicine (IOM) issued a report entitled, “Bridging the 
Gap Between Practice and Research.” This report discussed the gap between 
what scientific research found to be effective treatment for substance abuse 
disorders and what is actually practiced in substance-abuse treatment settings. 
The IOM report was the first of a number of reports that suggested that this 
gap existed. In a second report issued by the IOM in 2001, it was suggested 
that it took roughly 17 years for an effective research-based treatment 
intervention to become commonly used in substance abuse treatment practice. 
These reports began a movement spearheaded by the federal government’s 
Substance Abuse and Mental Health Services Administration (SAMHSA) and 
the National Institute on Drug Abuse (NIDA), to close the gap between 
research and practice. Federal agencies have begun to address this issue in a 
number of different ways including, the establishment of the Clinical Trials 
Networks by the National Institute on Drug Abuse, to enhance the delivery of 
scientifically-based treatments to drug abuse patients and the recent 
development of the NIDA/SAMHSA Blending Initiative designed to help 
increase the use of evidence-based practices in clinical settings.
The following document discusses dissemination and implementation of 
evidence-based practices in substance-abuse treatment settings. This 
document also includes a collection of updated works taken from the Central 
East Addiction Technology Transfer Center’s (Central East) Dialogue 
newsletter related to evidence-based practices developed through the 
Blending Initiative. The articles describe how these evidence-based practices 
were implemented into practice at various treatment programs.
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The CTN is made up of 16 regional research 
centers, called nodes, dis tributed across the 
country. Each node is a partnership between 
research institutions and community treatment 
programs (CTPs). The nodes have areas of 
specialization such as targeting specific popula-
tions or inves ti gating certain treatment modalities.
Appalachian Tri-State Northern New England 
California–Arizona Ohio Valley 
Delaware Valley Oregon/Hawaii 
Florida Pacific Region 
Long Island Regional Southern Consortium 
Mid-Atlantic Southwest 
New England Texas 
New York Washington
CTN NodesEvidence-Based 
Practices:
What are They?
By Paula Jones and Aaron Williams
It is called the “cardiac assessment” and it can be applied
to various types of interventions. Those carrying out the
intervention “know in their heart” that it works. Certainly,
there are many circumstances in which we can trust 
intuition. However, it is much better to have concrete 
evidence that something works than to simply believe 
that it does.
On the other end of the spectrum from the cardiac 
assessment are evidence-based practices. These are 
interventions for which there is consistent scientific 
evidence demonstrating that the desired outcomes are 
obtained. Rigorous assessments, such as multiple 
randomized clinical trials, consensus reviews of 
available science, or expert opinion based on clinical 
observation, are conducted to identify such practices. 
Practices that are subjected to less rigorous review are 
sometimes called promising practices or best practices.
The advantage for service providers in using evidence-
based practices is that there is a very strong probability 
that the specified outcomes will be achieved. For 
providers working in a challenging field like substance 
abuse treatment, in which relapse is common for 
patients, the use of evidence-based practices can give 
them a decided edge as they work to help people 
overcome their addictions.
Not only can the use of evidence-based practices 
improve the final outcome, it can also improve the work 
environment and an agency’s bottom line. Staff have 
clear guidance on how to carry out their duties and the 
expectationthat their efforts will show results. Funders 
have the assurance that resources are being directed 
toward something that will work, not something that 
might work.
Technology Transfer: Facilitating the 
Use of Evidence-Based Practices
In order to speed the use of any innovation into regular 
and routine practice, a process referred to as Technology 
Transfer is used. While the scientific community differs 
over the specific definition of technology transfer and 
the components of this process, simply put, it is defined 
as the multidimensional process that intentionally 
promotes the use of an innovation. Over the past year, 
the Addiction Technology Transfer Center (ATTC) 
network, funded by the Substance Abuse and Mental 
Health Services Administration’s (SAMHSA) Center for 
Substance Abuse Treatment (CSAT), has been reviewing 
the research literature in order to develop a common 
language and understand ing of Technology Transfer 
and its core components. The ATTCs are a network of 
14 regional centers and a national office that are charged 
with improving the addiction treatment field through 
the dissemination of evidence-based practices. After 
reviewing the research, the ATTC network came up 
with a more formal definition of Technology Transfer 
and its core components to help guide its work related 
to disseminating evidence-based practices.
Technology Transfer – A multidimensional process
that intentionally promotes the use of an innovation. 
Technology transfer begins during the development of 
an innovation, continues through its dissemination, and 
extends into its early implementation. This process 
requires multiple stakeholders and resources, and 
involves activities related to the translation and 
adoption of an innovation. Technology transfer is 
designed to accelerate the diffusion of an innovation.
DevelopmenT – Creating and initially evaluating an 
innovation. An innovation can be an idea, technology, 
treatment or method.
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TranslaTion – Explaining the essential elements and 
relevance of an innovation, then packaging it to 
facilitate dissemination.
DisseminaTion – Promoting awareness of an 
innovation with the goal of facilitating adoption and 
imple mentation. Dissemination strategies include 
raising awareness, building knowledge, and 
distributing materials.
aDopTion – The process of deciding whether to use 
an innovation. Adoption may or may not lead to 
implementation.
implemenTaTion – Incorporating an innovation into 
routine practice. Implementation ideally includes a 
range of strategies designed to address individual, 
organizational, and systemic characteristics (e.g., skills 
training, administrative buy-in, and policy changes).
Diffusion – The planned or spontaneous spread of an 
innovation.
How are Evidence-Based Practices 
Developed and Identified?
The National Institute on Drug Abuse (NIDA), part of 
the National Institutes of Health, supports over 85 
percent of the world’s research on the health aspects of 
drug abuse and addiction. NIDA’s mission is to lead 
the nation in bringing the power of science to bear on 
drug abuse and addiction. NIDA works to ensure the 
rapid and effective transfer of scientific data to policy 
makers, drug abuse practitioners, other health care 
practitioners, and the general public. Part of this effort 
is NIDA’s Clinical Trials Network (CTN).
The mission of the CTN is to use science as a vehicle to 
improve the quality of drug abuse treatment across the 
country. The CTN provides a forum by which NIDA, 
treatment researchers, and community-based providers 
can cooperatively develop, validate, refine, and deliver 
new treatment options to patients receiving treatment 
In order to illustrate our work, the ATTC Network 
has developed a cutting edge conceptual model of 
the diffusion of an innovation shown below.
First, during development, the innovation is 
designed and initially evaluated.  Next, during 
translation, the essential elements and relevance of 
the innovation are explained and the innovation is 
packaged to facilitate its spread. In dissemination, 
awareness about the innovation is promoted with 
the goal of encouraging its adoption. Adoption is 
not a single decision, but a process of deciding to 
use the innovation. Finally, during implementation, 
the innovation is incorporated into routine practice 
in “real world” settings.  Across the continuum, 
bidirectional communication is a critical component 
and is represented by a continuous feedback loop.
Highlighted within the conceptual model is 
technology transfer, a multidimensional process 
that intentionally promotes the use of an innovation. 
Technology transfer begins during development, 
continues through dissemination, and extends into 
early implementation. This process requires multiple 
stakeholders and resources, and involves activities 
related to translation and adoption. Technology 
transfer is designed to accelerate the diffusion of 
an innovation.
Diffusion of an Innovation
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from community-based providers. This unique 
partnership aims to achieve the following objectives:
•	 Conducting	studies	of	behavioral,	pharma	co­
logical, and integrated behavioral and pharma-
cological treatment interventions of therapeutic 
effect in rigorous, multi-site clinical trials to 
determine effectiveness across a broad range of 
community-based treatment settings and 
diversified patient populations; and
•	 Ensuring	the	transfer	of	research	results	to	
physicians, clinicians, providers, and patients.
Why is the CTN necessary? Traditionally, the efficacy 
of new treatments for drug addiction have been 
demonstrated in specialized research settings, usually
with limited patient populations. Such environments are
often fairly removed from the “real world” and do not
have to take into consideration the challenges facing real
providers. For these new treatments and treatment
approaches to fulfill their promise, advances achieved in
research settings must be “transferred” to community-
based settings where most treatment is provided.
Since the CTN was formed, 25 studies have been 
completed; three are currently underway. The studies 
have addressed a range of research topics including: 
use of Buprenorphine/Naloxone for opiate detoxi fi ca-
tion in both inpatient and outpatient settings; motiva-
tional interviewing; use of motivational incentives; 
brief strategic family therapy for adolescent drug 
abusers; reducing HIV/STD risk behaviors; HIV/HCV 
risk reduction interventions; and others.
With each of the studies, the research institutions pair 
with clinical treatment providers (CTPs). The CTPs 
provide the “real world” test for the intervention. 
Researchers and CTP staff work together to ensure that 
the intervention is applicable in the field. CTP staff 
receive training on how to implement the intervention 
and funding is often provided to support the additional 
activities required to conduct the intervention.
To help streamline this process of identifying evidence-
based practices SAMHSA has developed the National 
Registry of Evidence-based Programs and Practices 
(NREPP).
NREPP is a system designed to support informed decision
making and to disseminate timely and reliable infor -
mation about evidence-based interventions that prevent
and/or treat mental and substance use disorders.
The NREPP system allows users to access descriptive
information about interventions as well as peer-reviewed
ratings of outcome-specific evidence across several 
dimensions. NREPP provides information to a range of 
audiences, including service providers, policy makers, 
program planners, purchasers, consumers, and re-
searchers. The NREPP website (www.nrepp.samhsa.gov)
includes a search function that allows you to more 
easily scan through the programs and practices 
contained in the database.
Getting the Word Out: Dissemination 
of Evidence-Based Practices
What is the use of identifying evidence-based practices 
if there is no mechanism in place to get the word out to 
the field about their effectiveness? To effectively 
disseminate research findings, the CTN collaborates 
with the Substance Abuse and Mental Health Services 
Administration (SAMHSA) supported Addiction 
Technology Transfer Centers (ATTCs) through the 
NIDA/SAMHSA-ATTC Blending Initiative.
Developed in 2001, the Blending Initiative is designed to
meld science and practice together to improve substance
use disorder treatment and to move important 
scientific findings into mainstream addiction treatment 
practice. “Blending Teams,” made up of staff from the 
ATTCs along with CTN researchers and CTP repre-
sentatives, work together to develop a strategic plan 
and products to disseminate research results identified 
by NIDA. The ultimate goal is the adoption and 
implementation of evidence-based practices.
To date, five blending teams have been formed to
disseminate important findings to the field. For example,
when Buprenorphine was approved for the treatment 
of opioid addiction, a blending team was formed to 
educate the field about this new treatment option. The 
Buprenor phine Awareness Blending Team developed a 
training package to create awareness about Bupre nor-
phine among multi-disciplinary addiction professionals.
The materials include information designed to increase 
motivation for bringing Buprenorphine to local 
communities, as well as information about what to 
expect when someone is treated with this medication. 
Other blending teams include:
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•	 Treatment	Planning	M.A.T.R.S.,	using	the	
Addiction Severity Index (ASI) Blending Team;
•	 Motivational	Interviewing	Blending	Team;
•	 Buprenorphine	Detoxification	Blending	Team;	and
•	 Promoting	Awareness	of	Motivational	Incentives	
Blending Team.
Challenges to Adoption and 
Implementation of Evidence-Based 
Practices
Even though they have been proven to be effective in 
bringing about the desired outcomes, evidence-based 
practices are not always easy for CTPs to implement. 
A significant barrier is resistance from CTPs and their 
staff. People do not like change and the implemen-
tation of new practices often requires change. Adminis-
trative processes must be modified and staff must be 
trained. Given the effort required, CTPs may have 
doubts about a specific practice. Will it work? Is it 
worth the effort to implement it?
The need for training is a significant barrier and staff 
“buy in” is essential to ensure the successful implemen-
tation of a new practice. Staff may see efforts to adopt 
new practices as a criticism of their performance, an 
indica tion that they were not doing a good enough job. 
Staff may also not agree with a specific practice, such as 
providing clients incentives to remain in treatment, and
therefore be resistant to implementing these approaches.
Appropriate training can help to address such mis con-
ceptions. Even with staff buy in, training requires time 
and resources, which are usually scarce commodities 
in CTPs. Ideally, training should be ongoing to ensure 
that staff maintain their skills and to accommodate 
staff turnover.
No matter whether staff are receptive or resistant, it is 
incumbent on management to ensure that the practice 
is implemented as intended by the researchers. To 
achieve the same outcomes as the researchers, CTPs 
must follow the same process in implementing the 
practice as was done in the clinical trial. This is called 
fidelity. If the practice is not properly implemented, it 
is unlikely that the desired outcomes will be achieved. 
Sometimes modifications to a practice are necessary, 
that’s the real world, but these changes should be made 
consciously. Changes to the protocol should not be 
done by accident or due to lack of attention.
Finally, funders may not recognize the value of a specific
evidence-based practice and may not be willing to 
support it. The question of funding is not a minor one.
When they participate in the CTN process, CTPs are often
provided additional support to carry out the required
activities. This is rarely the case in the “real world.” CTPs
that implement best practices outside of a clinical trial
must obtain the resources to carry out the new activities.
Unsupportive funders can make this difficult.
Keys to Success
What elements are key to the successful implemen-
tation of evidence-based practices? One is to have a 
“champion” within the organization who supports the 
implementa tion of the practice and ensures that the 
practice is main tained once it is implemented. The 
issue of maintenance is significant. Once implemented, 
even with initial enthusiasm, new practices can 
gradually fall to the side as staff revert to their former 
practices. A champion can help to make sure that new 
practices are maintained.
How a new practice is introduced into an organization 
can make a big difference. Often, training is too limited, 
just one or two sessions. This has no staying power. 
A new practice must be “infused” into an organization. 
Training must be seen as an ongoing process, not a 
one-shot deal.
Finally, the effectiveness of the new practice must be 
evaluated. If the practice is implemented, following the 
researchers’ protocol, there is a strong probability that 
the provider will see positive results. However, this is 
not an absolute guarantee. A thorough evaluation 
process will help the provider measure the outcomes. 
It will also help to identify areas where the practice has 
been incorrectly or not fully implemented, or areas 
where adjustments are needed. Evaluation can also 
help providers measure successful implementation, 
which can result in greater support for the practice by 
staff, funders, and most important of all, clients.
Resources
NIDA Clinical Trials Network
For more information on the CTN go to: 
www.nida.nih.gov/CTN/index.htm
NIDA/SAMHSA Blending Initiative
For more information on the NIDA/SAMHSA 
Blending Initiative, include the training packages go to: 
www.attcnetwork.org/explore/priorityareas/science/ 
blendinginitiative/index.asp
6
Short-Term Opioid Withdrawal 
Using Buprenorphine: An Example 
from the Field
By Paula Jones
When it was approved by the U.S. Food and Drug Administration (FDA) for treatment of 
opioid addiction in 2002, buprenorphine was seen as providing important new treatment 
options, treatment for opioid addiction could now be provided in medical settings, such as 
physicians’ offices, rather than limited to methadone treatment facilities. By bringing opioid 
addition treatment into mainstream medical settings, buprenorphine has greatly expanded 
access to treatment.
In addition to use in maintenance treatment, 
buprenorphine is being used for medically 
monitored detoxification. With this treat-
ment, medications such as bupre nor phine 
help to suppress withdrawal symptoms 
during detoxification. It is important to note 
that by itself, medically assisted withdrawal 
does not constitute treatment it is only the 
first step in the treatment process. Without 
further treatment, relapse is likely.
Not all medically monitored detoxification 
programs are the same, especially in terms 
of the length of treatment. Programs can 
be as short as 5 days or considerably longer. 
However, there are important key elements 
to detoxification treatment. These include: 
evaluation/assessment; stabilization; and 
preparation for substance abuse treatment. 
The following profile provides one example 
of a medically managed detoxification 
program.
Kent/Sussex Detoxification 
Center
The Kent/Sussex Detoxification Center is a 
clinically managed residential program 
serving clients addicted to heroin, cocaine, 
crack, marijuana, prescription drugs, and 
alcohol. The Center, a 20-bed facility located in Ellendale, Delaware, provides uninsured 
adult residents of the state access to detoxification from drugs and alcohol. About four years 
ago, the Center began offering medically monitored detoxification treatment using bupre-
norphine. Since then, the Center has provided detoxification treatment with buprenorphine 
to approximately 1,000 clients.
The Center takes a holistic approach to treatment, offering a wide range of services over the 
course of the 7-day treatment for opioid detoxification. These include:
•	 Buprenorphine	is	a	long­acting	partial	mu	opiate	
agonist that acts on the receptor targets of heroin and 
morphine but does not produce the same intense 
“high” or dangerous side effects.
•	 Buprenorphine’s	formulation	with	naloxone,	an	opioid	
antagonist (Suboxone), limits abuse by causing severe 
withdrawal symptoms in those who inject it. How ever, 
there are no adverse effects when it is taken orally 
(naloxone is minimally absorbed when taken orally).
•	 The	FDA	approved	use	of	Subutex® (buprenorphine) 
and Suboxone® tablets (buprenorphine/naloxone) in 
October 2002. A large NIDA-sponsored, multi-site 
clinical trial demonstrated that buprenorphine signifi-
cantly reduced opiate use and drug cravings in heroin 
users and confirmed its safety and acceptability.
•	 In	2000,	Congress	passed	the	Drug	Addiction	Treatment
 Act, allowing qualified physicians to prescribe narcotic 
medications (Schedules III to V) for the treat ment of 
opioid addiction, which allowed access to heroin 
treatment in a medical setting other than methadone 
clinics.
Source: National Institute on Drug Abuse 
www.nida.nih.gov/DrugPages/buprenorphine.html
Buprenorphine Basics
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•	 Medical	assessment	and	individualized	treatment	
plans for detoxification;
•	 Individualized	assessment	and	referral/placement
 in treatment programs and individual sessions to 
prepare clients for treatment;
•	 Educational	groups	on	the	process	of	recovery,	
relapse prevention, self help, and medical issues;
•	 Special	groups	session	on	work	opportunities,	
women’s issues, and literacy;
•	 Alternative	therapy	such	as	acupuncture,	reiki,	
and guided imagery;
•	 Daily	open	fellowship	(12­step)	meetings;
•	 Tuberculosis	testing;
•	 HIV	counseling	and	testing;
•	 STD	counseling;
•	 Vaccination	for	Hepatitis	B.
According to David Beling, MS, CADC, the Center’s 
Substance Abuse Program Administrator, use of 
buprenorphine is critical to the success of this holistic 
approach. “Buprenorphine is a great asset to us since 
we offer all these additional services. The bupre nor-
phine allows us to do the other things that we want to 
do with our clients and to set them up for the best 
possible aftercare. It allows clients to focus on their 
issues. It helps us get them to where they need to be.”
Clients have been very receptive to the treatment. 
“They love it,” reports Beling. “It works very well and 
there has been little to no mention of side effects.”
A Change in Mind Set
Beling reports that integrating the use of buprenorphine
was relatively easy, with no complaints from either 
staff or clients. The facilities medical director, Dr. 
Nathan Centers, plays an important role in the treat-
ment and was a driving force in implementing the 
treatment protocol in the Center. “He believes in the 
use of the best available treatment practices,” reports 
Beling. “Buprenorphine is a best practice.”
There have been some critics of use of buprenorphine, 
both in general and for detoxification. “Some people 
think it is too easy, that it is a quick and easy fix,” states 
Beling. “Yes, there are some people who might think 
that they can go ahead and take drugs and then just 
use buprenorphine to get off them. But making people 
suffer doesn’t always give you the response you want 
or your clients need.”
1. Detoxification, in and of itself, does not constitute complete substance abuse treatment.
2. The detoxification process consists of three essential components, which should be available to all people 
seeking treatment:
	 •	 Evaluation;
	 •	 Stabilization;
	 •	 Fostering	patient	readiness	for	and	entry	into	substance	abuse	treatment.
3. Detoxification can take place in a wide variety of settings and at a number of levels of intensity within 
these settings. Placement should be appropriate to the patient’s needs.
4. All persons requiring treatment for substance use disorders should receive treatment of the same quality 
and appropriate thoroughness and should be put into contact with substance abuse treatment ¬providers 
after detoxification.
5. Ultimately, insurance coverage for the full range of detoxification ¬services is cost-effective.
6. Patients seeking detoxification services have diverse cultural and ethnic backgrounds as well as unique 
health needs and life situations. Programs offering detoxification should be equipped to tailor treatment to 
their client populations.
7. A successful detoxification process can be measured, in part, by whether an individual who is substance 
dependent enters and remains in some form of substance abuse treatment/rehabilitation after 
detoxi¬fication.
Source: TIP 45. Detoxification and Substance Abuse Treatment 
www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat5.section.85295
Detoxification: Basic Principles
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Response to Treatment
The use of buprenorphine has been successful at 
multiple levels. Initially, when the Center first started 
offering the treatment they were overwhelmed with 
people coming from outside the state seeking access to 
the treatment. Unfortunately, the Center can only serve 
Delaware residents, but it was clear the service was 
very much in demand. The Center averages about 
12.5 clients a day in the program. The Center is cur-
rently exploring the possibility of providing services to 
clients with health insurance, which should keep it 
near capacity.
Beling estimates that about 90 percent of clients go 
on to other treatment programs, although not all of 
the clients continue on buprenorphine treatment. 
Dr. Centers is the medical director at two other facilities 
and is working to incorporate buprenorphine treatment 
at these sites. This will facilitate the transition of clients. 
While there is no formal evaluation component to the 
program, Dr. Centers is planning to survey clients after 
they leave the program (at 6 months and1 year) to 
assess the success of the treatment.
This article was first published in the Fall 2007 edition of the 
Dialogue.
NIDA/SAMHSA Blending Initiative Resources
The NIDA/SAMHSA Blending Initiative is designed 
to translate research into practice and to facilitate 
communication between stakeholders to make the 
best drug abuse and addiction treatments available 
to those who need them. Blending Teams are 
composed of NIDA researchers, community-based 
substance abuse treatment practitioners, and trainers 
from SAMHSA's Addiction Technology Transfer 
Center (ATTC) Network. The teams work to develop 
resources based on research conducted within 
NIDA's Clinical Trials Network (CTN) as well as 
other research supported by NIDA. Blending Team 
members design dissemination products to facilitate 
the adoption of science-based interventions. To date, 
two Blending Teams have developed products 
related to buprenorphine.
Buprenorphine Treatment: Training for 
Multidisciplinary Addiction Professionals
The Buprenorphine Treatment Blending Team 
developed a training package to disseminate infor-
mation and enhance awareness among addiction 
professionals about buprenorphine treatment.
Products
•	 Training	manual	for	6­hour	classroom	modules
•	 PowerPoint	presentation	and	CD
•	 Annotated	bibliography
•	 Training	Video
•	 Research	articles
Short-Term Opioid Withdrawal Using 
Buprenorphine: Findings and Strategies from 
a NIDA Clinical Trials Network Study
This training package focuses on the administration
of a 13-day buprenorphine taper for opioid-dependent
patients. The training reviews results from research 
conducted by the CTN comparing buprenorphine 
versus clonidine in both inpatient and outpatient 
settings. The training provides instruction for 
implementing this protocol into treatment settings. 
Topics addressed include methods of evaluation and 
induction, the taper schedule, and use of ancillary 
medications during treatment.
Products
•	 4­hour	classroom	training	program	addressing:
 – Rationale for providing detoxification to
  opioid-dependent patients;
 – Characterization of opiate withdrawal;
 – Goals of detoxification;
 – Results of the CTN studies;
 – Implementation training;
 – Patient and treatment staff perspectives;
 – Overdose risk following detoxification.
•	 PowerPoint	slides	and	CD
•	 Brochure
To access these resources go to: www.attcnetwork.org/
explore/priorityareas/science/blendinginitiative/
index.asp
Currently, as part of the NIDA Blending Initiative, the two buprenorphine training products are being 
updated to include information from a recently completed NIDA clinical trials study related to the use of 
buprenorphine in young adults. The updated products will be available in the winter of 2009.
Source: NIDA InfoFacts: Treatment Approaches for Drug Addiction 
www.drugabuse.gov/Infofacts/treatmeth.html 9
Confirming the Effectiveness 
of an Evidence-Based Practice: 
Use of Motivational Interviewing in 
the Real World
By Paula Jones
“The study confirmed what clinical research had shown, that motivational interviewing is an 
empirically validated approach that is effective in clinical practice.”
These are the words of Kathleen Carroll, PhD, of the Division of Substance Abuse of the Yale 
University School of Medicine’s Department of Psychiatry. Dr. Carroll served as principal 
investigator on a clinical trial supported by the National Institute on Drug Abuse’s Clinical 
Trial Network (CTN). The trial explored the effectiveness of integrating motivational 
interviewing (MI) techniques into the intake process of community-based substance abuse 
treatment providers. While there is ample evidence indicating that MI is an effective 
approach, little data were available on whether the approach could be integrated into 
standard clinical practice and whether it would result in improved patient outcomes. This is 
precisely the role of the CTN, to demonstrate that research-proven approaches, also known 
as evidence-based practices, can work in community settings.
Motivational interviewing is defined as a directive, client-centered counseling style for eliciting
behavior change by helping clients explore and resolve ambivalence about changing problem 
behaviors. The concept of MI was first described by William R. Miller, PhD, in 1983 and elab-
o rated on by Miller and Stephen Rollnick, PhD, in 1991. Motivational interviewing is focused
and goal directed, with its central purpose being the examination and resolution of ambivalence,
which can be defined as simultaneous and contradictory attitudes or feelings, continual 
fluctuation, or uncertainty as to which approach to follow. Motivational interviewing is 
considered to be an approach to counseling, not a specific counseling technique.
The CTN brings together researchers and community-based clinicians to “bridge the gap” 
between research and practice. In the case of this clinical trial, the community-based 
providers were very enthusiastic about integrating MI techniques.
“The boat had already launched on this one. 
There were no significant barriers to 
implementation and MI was generally seen 
as very attractive by the clinicians. We just 
had to figure out how to structure the study 
in community-based sites,” relates Carroll.
Five community-based treatment programs 
participated in the study. Three sites were in 
Oregon, one was in Virginia, and one was in 
New York. All the sites offer pre dominantly 
group-based treatment. This provided a 
challenge to the researchers since MI is more 
of an individualized approach. To address 
this, the MI inter vention was integrated into 
the individual intake/assessment session 
that takes place before the patient is 
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•	 Motivation	to	change	is	elicited	
from the client, and not imposed 
for the outside.
•	 The	client,	not	the	counselor,	must	
articulate and resolve his or her 
ambivalence.
•	 Direct	persuasion	is	not	an	
effective method for resolving 
ambivalence.
•	 Counseling	should	be	done	in	a	
quiet and eliciting manner.
•	 The	counselor	should	be	directive	
in helping the client examine and 
resolve ambivalence.
•	 Readiness	to	change	is	not	a	
permanent, ongoing state; it 
fluctuates based on interpersonal 
interaction.
•	 The	therapeutic	relationship	
should be viewed as a 
partnership.
Source: Rollnick, S. and Miller, W.R.
What is motivational interviewing? 
Behavioral and Cognitive Psycho - 
therapy, (23): 325-334, 1995.
Characteristics of
Motivational Interviewing
assigned to group treatment. The research focused on whether this 
relatively brief intervention would enhance retention and 
substance abuse outcomes.
A key aspect of the study was the training component for the 
clinicians. “It was important for us to think about what would 
work in community settings and how to best help clinicians deliver 
the services,” relates Carroll.
A decentralized training model was adopted that was designed to 
provide consistent, high-quality training as well as ongoing super-
vision, the trainers would also supervise the clinicians and review 
tapes of the MI sessions to evaluate the clinicians adoption of the 
intervention. An MI expert trainer, with extensive experience in 
training and supervising clinicians in MI, was identified for each 
site. These experts attended an initial “training-of-trainers” seminar 
designed to standardize the training. The trainers then returned 
to the sites to train clinicians as well as the clinical supervisors at 
each site.
The training included review of MI principles and practices, use of 
training videotapes, lots of role playing to help in the development 
of skills, and discussion of how to implement the study protocol. 
The majority of the training focused on practice and 
coaching, with clinicians completing three MI sessions 
that were then reviewed by the trainer. A key element 
of the training model was that it was designed to 
allow the sites to continue to deliver MI after the 
study ended. The supervisors received additional 
training in MI and assessment of clinician adherence 
and skill in delivering MI. It was envisioned that the 
supervisors would provide ongoing feedback and 
support to the clinicians and serve as an MI training 
resource at the site.
To determine the extent to which clinicians 
were successfully integrating MI into their 
interaction with clients during the single 
intake session, the sessions were taped 
and later reviewed. Taping and review 
of sessions with clinicians is also a 
valuable tool for super visors in the 
real world.
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•	 Seek	to	understand	the	patient’s	
frame of reference, especially 
through the use of reflective 
listening.
•	 Express	acceptance	and	
affirmation.
•	 Elicit	and	selectively	reinforce	the	
patient’s self-motivational 
statements, expressions of problem 
recognition, concern, desire and 
intention to change, and ability 
to change.
•	 Monitor	the	client’s	degree	of	
readiness to change and ensure 
that resistance is not generated by 
going too fast for the patient.
•	 Affirm	the	client’s	freedom	of	
choice and self-direction.
Source: Rollnick, S. and Miller, W.R. What 
is motivational interviewing? Behavioral 
and Cognitive Psychotherapy, (23): 325-334, 
1995.
Trainable Clinician Behaviors “To successfully implement MI, clinicians need training and support.
This means real supervision, listening to clinicians as they use MI 
with real clients. Clinicians often think they are doing it, but if you 
listen to the tapes there isn’t a lot of MI going on in the interaction 
with clients. Supervision and coaching is absolutely necessary,” 
emphasizes Dr. Carroll.
The study did not explore whether ongoing supervision is necessary
to ensure that clinicians continue to effectively use MI approaches. 
Dr. Carroll hopes to explore this question in the future. “Programs 
need to provide feedback, coaching and support. It is not enough 
to just to implement the intervention. People may change things or 
make some adaptations but the question remains whether there is 
enough MI taking place and whether it is done in a skillful way.”
Dr. Carroll cites three important finding from the study. First, 
community-based clinicians can learn to implement MI effectively 
with training and supervision. Secondly, the training and super-
vision associated with the intervention enhanced the skills of the 
clinicians that received it. Clinicians that received the MI training 
were assessed by independent reviewers as more skillful overall, 
not just in the provision of MI, than their colleagues who did not 
receive training. Thirdly, MI significantly increased the rate of client 
reten tion, which is an important marker of treatment success. 
Motivational interviewing helped to keep patients engaged in 
the program.
The clinicians who participated in the study were volunteers. Thus, 
they tended to have an interest in MI and want to incorporate the 
approach into practice. The only issue of concern for most of the 
clinicians participating was how to employ the MI approach for 
patients who did not want to be in treatment. This issue was 
addressed in the training and through supervision. In general, the 
clinicians found that the approach could be applied to a wide range 
of individuals.
Dr. Carroll believes that many of the sites that participated in the 
study are continuing to use the MI approach. “It is hard to unlearn 
something like this,” she relates. “The clinical supervisors are very 
interested in MI.” She points out that for any community-based 
programs the training needs are ongoing, given staff turnover and 
the need for supervision to ensure that the approach is fully and 
correctly implemented.
The CTN has supported other studies that have explored MI. 
Dr. Carroll and her colleagues at Yale have studied the feasibility 
and impact of a three-session intervention in both English and 
Spanish. An additional study looks at the use of motivational 
approaches with pregnant women.
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Integrating Research into Practice
The Motivational Interviewing Blending Team is working to 
develop and disseminate tools that will help community-based 
providers integrate MI into their practice. An array of materials for 
this package have been developed. The package, entitled Moti va-
tional Interviewing Assessment: Supervisory Tools for Enhancing 
Proficiency (MIA:STEP), includes both information on the results of 
the trial that can be used to educate policymakers and providers, 
on evidence-based MI practices, as well as tools to enhance 
counselor supervision.
The Blending Team focused on supervisors and the important role 
they play in working with counselors to ensure that they are fully 
and effectively implementing MI. Many of the materials developed 
are designed to build the skills of supervisors or are designed for 
supervisors to use in the training or evaluation of counselors. 
Materials include a tape rating guide for supervisors, an audio CD
with four examples of standardized MI assessments (two in English
and two in Spanish), and a self assessment of skills for counselors.
“The focus of the blending package is to assist supervisors in 
increasing the proficiency of MI-practicing clinicians,” states 
Denise Hall, LPC, NCC of the Mid-Atlantic ATTC. “When an 
agency implements an evidence-based practice, supervisory 
knowledge as well as the ability to apply and transfer that 
knowledge is imperative for sustainability.”
The tools are designed to help supervisors develop the skills 
necessary to rate the tapes of counseling sessions to determine the 
extent to which counselors are effectively using MI techniques. The 
rating system is the same as the one that was used in the CTN 
clinical trial. It was developed by Dr. Carroll and her colleagues at 
Yale and modified to make it more applicable for community 
providers.
The Blending Team released the materials for this package and 
they are currently available on the national ATTC website at: 
www.attcnetwork.org/explore/priorityareas/science/
blendinginitiative/miastep/index.asp. Because the materials are 
complex, the Blending Team is planning to use a train-the-trainer 
approach to support the dissemination of the package. Trainings 
will be held on a regional basis.
“The package is designed to be part of a comprehensive MI training
initiative. MIA: STEP represents a continuum of learning through 
experience for both the supervisor and clinician,” states Hall.
For More Information
Motivational Interviewing 
www.motivationalinterviewing.org
NIDA/SAMHSA-ATTC Blending 
Initiative 
www.attcnetwork.org/explore/
priorityareas/science/blendinginitiative/
index.asp
This article was first published in the Fall 2006 
edition of the Dialogue.
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Integrating Evidence-Based Approaches: 
A Provider’s Perspective
In order to obtain a better perspective of what it is like for 
providers to implement an evidence-based approach, we 
asked Ned Snead, manager of adult substance abuse 
services at the Chesterfield Department of Mental Health 
and Support Services his opinion on being apart of a 
CTN study. 
What is the appeal of participating in a CTN clinical 
trial for providers and their staff?  Participating in 
the MI clinical trial proved attractive to providers on 
several levels including the possibility of improved 
outcomes, enhanced staff skills, and an increased 
receptiveness on the part of staff to adopting addi-
tional evidence-based practices.
“Since the MI clinical trial, our retention rates have 
gone up and up. If clients engage, we are keeping 
them in treatment longer,” relates Snead.
To benefit from the CTN process requires commitment
from an organization and its staff. Management 
plays a significant role in both the implementation 
of the trial and in garnering staff support.
To integrate the research protocol, supervisors had to
work closely with the researchers to make sure that 
the recruiting process was compatible with existing
organizational processes. This required working with
the research team for several hours each week to
tweak the process in order to meet recruitment goals.
According to Snead, while staff was generally receptive
to participating in the study and incorporating MI,
there was some ambivalence about adding something
new. “There was some fear about adding additional 
stresses to an already overloaded system. Staff had 
their own ambivalence about this change but were 
able to work through it with patience, support, and 
persistent encouragement,” states Snead. “For the 
most part though, staff was very receptive.”
Participation in the trial was voluntary for staff. 
Those participating agreed to the taping of client 
sessions and increased supervision. An indication of 
the level of staff interest in participating occurred 
when one of the counselors participating in the trial 
resigned. Several other staff members stepped 
forward to join the trial.
“We have a very inquisitive staff. They are extremely 
interested in improving their skills and their ability 
to serve clients,” relates Snead. “Staff saw 
participation as an opportunity to get additional 
training at little or no cost to the organization.”
The impact of the clinical trial has been ongoing 
within the organization. Participation in the initial 
CTN study increased staff’s receptiveness to 
integrating evidence-based practices; it showed 
what could be done. Since the initial trial, 
supervisors and staff teams have incorporated other 
evidence-based practices. “Staff is empowered to 
identify and solve problems,” states Snead. “Now, 
people step up with new ideas and concepts.”
In addition, the use of MI has been expanded within 
the organization. All substance abuse staff have been 
trained in MI and there is ongoing supervision with 
two MINT (Motivational Interviewing Network of 
Trainers) clinical supervisors, Tom Mullins and Janet 
Loving. Plans are in place to video and audiotape 
client sessions in order to provide more feedback to 
staff on their effectiveness. Motivational inter-
viewing techniques have also been integrated into 
some group sessions, using an evidence-based 
approach, the Motivational Groups for Community 
Substance Abuse Programs model, which was 
authored by Karen Ingersoll, Christopher Wagner, 
and Sandra Gharib of the Mid-Atlantic ATTC.
Following the MI clinical trial, Snead and his staff 
participated in a second CTN trial. They have found 
that incorporating one evidence-based approach is 
good, but incorporating a variety of evidence-based 
approaches is better. “If there is a good fit, we would 
gladly participate in additional trials,” states Snead.
Snead stresses that not every evidence-based 
approach, including MI, is appropriate for each staff 
person and all situations. “MI is not used all the 
time and some counselors use it more effectively 
than others. Some don’t use it at all, it is not in their 
skill set. You can’t expect everyone to use MI. There 
needs to be a variety of approaches available for the 
diverse individuals we serve.”
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Motivational Incentives: 
Useful Tool in the Improvement of 
Treatment Outcomes
Providing Positive Reinforcement with Motivational Incentives
National Study Explores Impact on Abstinence and Attendance
By Paula Jones
Every parent is aware of the benefits of using rewards to influence their children’s behavior, 
especially when it comes to encouraging them to do something that may be difficult. Parents 
know that positive reinforcement can work wonders. The same approach can be used to 
motivate drug users in outpatient substance abuse treatment to remain in treatment and 
abstain from drug use. The use of rewards, also referred to as incentives, in treatment is 
called contingency management (CM). CM interventions are based on behavioral research 
indicating that reinforcing a behavior can increase its frequency.
The efficacy of CM interventions has been demonstrated in patients dependent on opioids, 
marijuana, alcohol, and cocaine. Many of the studies of CM interventions have provided 
vouchers to patients, contingent on them attending treatment and/or abstaining from drugs. 
Despite the proven effectiveness of vouchers, some issues have hindered the adoption of this 
strategy in community-based programs. The primary issue is cost; in some studies partici-
pants could earn more than $1000 in vouchers. It is unlikely that many local programs could 
find the funds to support this level of reward.
Researchers at the Johns Hopkins University (JHU) School of Medicine conducted a clinical 
trial at eight community-based drug treatment sites across the country to explore the 
effectiveness of intermittent incentives. A chance to win a prize would be used to reinforce 
behavior instead of a guaranteed prize, the assumption being that a chance of winning was 
as good as a sure thing. The study is supported by the National 
Institute of Drug Abuse’s (NIDA) National Drug 
Abuse Treatment Clinical Trials Network (CTN).
In the CTN study, patients earned a chance to 
draw chips from a container and win prizes of 
varying magnitudes. The difference between the 
voucher and the intermittent, prize-based studies is 
that with vouchers, patients receive a reward every 
time. In the prize-based study, 50 percent of the chips 
in the container stated “Good Job” and no prize was 
received by the participant. In the CTN study, an average 
of $400 in prizes could be won over 3 months if a participant 
submitted urine samples that tested negative for all target drugs 
(stimulants, opiates, and marijuana) as well as negative breath 
alcohol tests. This intermittent model is a much more affordable 
option for community-based providers.
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The JHU study is part of the clinical trials process
supported by the National Institute of Drug Abuse’s
National Drug Abuse Treatment Clinical Trials 
Network (CTN).
Participating in research can create challenges for 
the community treatment programs. Many have 
never participated in clinical trials before.
“Staff was open to the process but it was different 
from anything we had done. Research uses 
different language, requires different training, 
and has different expectations,” relates Patricia 
Quinn Stabile, Program Director at HARBEL 
Prevention and Recovery Center in Baltimore, 
one of the sites in the JHU study. “We had to find 
common goals and provide training to staff.”
To find out more about the CTN, go to: 
www.nida.nih.gov/CTN/index.html
Clinical Trials Network
While the study explored the impact of incentives 
awarded for drug negative urine samples under a 
particular set of procedures, Maxine L. Stitzer, PhD, 
principal investigator for the study, emphasizes that 
with incentives, the most important thing is the 
principle of positive reinforcement.
The researchers were fully aware of the challenges of 
sustaining an incentive program, particularly the 
financial challenges, and used a protocol that could 
make these programs more feasible for community 
clinics. Stitzer emphasizes that programs may not have 
the ability or the interest to implement the study 
protocol exactly as it was done in the CTN trial.
“Hopefully programs will adopt the principles of positive
reinforcement and tailor the prize draw approach to 
their own clinical goals and patient needs,” she states. 
“Positive reinforcement should be integrated through-
out programs and the successes of clients should be 
celebrated. Bringing a positive spin to treatment can be 
great for the morale of both clients and staff.”
Stitzer explains that many clients have received very 
little positive reinforcement in their lives and it can 
serve as a strong motivator. In addition, there is a 
prevailing attitude that clients should not be rewarded 
for what they should be doing anyway, which does not 
recognize the benefits that can be gained from 
reinforcing positive behavior.
The primary hypotheses of the CTN study were that 
participants receiving the incentives would remain in 
the study longer, submit more stimulant- and alcohol-
free samples, provide a higher percentage of stimulant- 
and alcohol-free samples, and remain abstinent from 
these drugs for a longer period of time. The researchers 
also hypothesized that participants receiving incentives 
would attend more counseling sessions and submit a 
higher proportion of samples free of opioids and 
marijuana than participants receiving regular care.
The multi-site study provided a unique opportunity to 
evaluate the intervention within the context of the care 
provided at each site. Both the content and intensity of 
standard therapy were expected to vary across sites, as 
were usual care outcomes. By studying the intervention 
across several sites, the researchers could explore 
whether the intervention had an impact with different 
patient populations and care practices.
The Study
A total of 415 cocaine or methamphetamine users 
beginning outpatient substance abuse treatment were 
enrolled in the study between April 2001 and February 
2003. Approximately half of the participants received 
standard care with the opportunity to receive prizes. 
The other participants received standard care. Standard 
care usually consisted of group counseling combined 
with some individual and family counseling.
To determine abstinence from drugs, participants were 
asked to provide two urine samples per week on non-
consecutive days for at total of 24 samples over the 
course of the study. The first sample was taken at 
intake. Participants also provided a breath sample at 
each visit that was tested for alcohol use.
For participants in the incentive group, when their test
results were negative for all the primary target drugs they
drew one to 12 chips from the container. Chips were
marked with one of four values: good job (50% of chips);
small (41.8% of chips); large (8% of chips); and jumbo 
(0.2% of chips). Draws increased by one for each week 
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Good Job 
No prize
Small 
Toiletries, snacks, bus tokens, fast food gift 
certificates (approximately $1 in value)
Large 
Kitchen objects, telephones, compact disc players, 
retail store gift certifi cates (approximately $20 
in value)
Jumbo 
Televisions, stereos, DVD players (approximately 
$80 to $100 in value)
Incentivesin which all the submitted samples were free of the 
primary target drugs. The number of draws returned to 
one if the participant had an unexcused absence or 
submitted a sample positive for a primary target drugs. 
To offset the lack of reinforcement early in the study 
when the number of draws was low, a single large 
prize was awarded after the first two consecutive 
weeks of abstinence. At each study visit, participants 
could also earn two bonus draws if their sample was 
free of opioids and marijuana. The maximum number 
of draws a participant could earn during the study was 
204, which resulted in an average of approximately 
$400 in prizes.
Results
Participants receiving incentives while being treated in
psychosocial counseling programs remained in treat ment
longer and attended more counseling sessions than 
those not receiving incentives. Those receiving 
incentives were also significantly more likely to achieve 
4, 8, and 12 weeks of continuous abstinence. The 
incentive group had approximately twice as many 
participants with at least 4 weeks and at least 8 weeks 
of documented abstinence. The percentage of 
participants with 12 weeks of abstinences was nearly 
four times greater in the incentive group.
The study shows that retention, whether it was defined
as the number of days between study intake and the last
study visit, the proportion of participants who submitted
samples each week, or the number of counseling 
sessions attended, was significantly lengthened when 
incentives were provided. Use of incentives also 
improved drug use outcomes. Little drug use was 
detected while patients remained in treatment. Thus, 
duration of sustained abstinence was lengthened 
during longer periods of treatment participation.
What is the Best Way to 
Use Incentives?
Since the researchers found many patients remained
abstinent while participating in psychosocial counseling
treatment, is it necessary to reinforce abstinence or 
should the reinforcement focus on attendance? The 
researchers suggest that incentives based on attendance 
may be a more beneficial approach. Focusing on 
attendance has additional benefits. For one, urinalysis 
frequency could be reduced, which would reduce the 
cost of administering the program. For the study, 
clinics were provided funds to hire a research assistant 
to conduct the urine testing, that is probably not a 
likelihood in the real world. In addition, the researchers 
suggest that attendance-based incentives might 
encourage patients who have relapsed to return to 
treatment rather than feeling they might be unwelcome 
because of their drug use. However, more research is 
needed to determine if this is the case.
“When individuals in treatment programs have already 
stopped using drugs, the main job of the provider is to 
keep them from relapsing,” states Stitzer. “Incentives, 
by helping people stay in treatment longer, may also 
give them more of a chance to learn the skills they need 
to stay off drugs.”
In the study, the sites that seemed to benefit most from 
the intervention were those with relatively low usual 
care retention rates (e.g., less than 7–8 weeks average 
retention). This indicates that the use of incentives may 
be most beneficial in clinics with low retention rates. 
However, since benefits were identified across all the 
sites, CM should be considered even when retention 
rates are relatively high.
The researchers had planned to explore the long-term 
impact of the CM intervention but were unable to 
follow up with a sufficient number of participants to 
draw any meaningful conclusions. Additional research 
is necessary to address the conditions under which CM 
can have a long-term impact in community-based 
settings.
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The ATTC-NIDA Blending Team focusing on 
motivational incentives, headed by Lonnetta 
Albright, Director of the Great Lakes ATTC along 
with Anne-Helene Skinstad, Director of the 
Prairieland ATTC and Amy Shanahan of the 
Northeast ATTC, has designed an awareness 
campaign, Promoting Awareness of Motivational 
Incentives (PAMI) that educates policymakers, 
administrators, and clinicians about motivational
incentives. The campaign uses a variety of vehicles,
such as Power Point slide sets and videos. Infor-
ma tion covered in the campaign includes: defini-
tions; history of theory and use of motivational 
incentives; core principles; past and current 
research, and clinical applications. Included in 
the packet is a toolkit that contains: articles, an
annotated bibliography, testimonials, sample letters
to policymakers, FAQs, and other resources to 
help programs learn more about motivational 
incentives and promote the idea in their com mu-
nity. The campaign focuses on how to operation-
alize lower-cost incentive interventions, such 
as the intermittent reward approach used in 
Dr. Stitzer’s study. To view or download this 
product go to: www.attcnetwork.org/explore/
priorityareas/science/blendinginitiative/pami/
index.asp or the ATTC in your region for more 
information.
Getting the Word Out
Barriers to the Use of Incentives
Despite ample evidence that incentives can enhance 
treatment, there are still barriers to incorporating their 
use in community programs. As stated previously, cost 
is a major factor. However, as more emphasis is placed 
on evidence-based practices, funding agencies may be 
more inclined to provide resources for incentives. 
Clinics that operate under contracts where they are 
paid for units of service provided could increase their 
income by using incentives to motivate regular 
attendance at scheduled sessions. Some public sector 
funders are agreeing to support incentives when they 
are included by grantees as a line item in their budgets.
“Since the study we have done several small, limited
projects that have used incentives,” relates Quinn Stabile
of HARBEL Prevention and Recovery Center. “We 
haven’t been able to continue to use them as we did in 
the study but we are working to bring them back.”
Another barrier is training. While the intervention may
seem relatively easy to implement, staff need training on
how to incorporate incentives into the overall program.
Not only do attitudes need to be changed but new skills
are also necessary. Ideally, training should be an ongoing
process with regular feedback provided to staff.
Closely related to the training issue is the challenge of 
implementing a new process into the existing treatment 
protocol.
“It was more complicated to implement the use of
incentives than we had anticipated,” states Quinn Stabile
of HARBEL. “We needed to track the use of incentives 
and make sure that they were provided in a fair way.”
Perhaps the greatest remaining barrier is attitudes. 
From administrators to frontline staff, there needs to be 
an acceptance of rewarding clients’ positive behavior.
“The take home message is the idea of celebrating 
success by applying positive reinforcement in the 
clinic,” states Stitzer. “Each clinic can look at its own 
situation and decide what is important to it and their 
clients in terms of incentives.”
While attitude is a barrier, it is not insurmountable.
“Some staff were resistant but others immediately 
understood the use of incentives. We emphasized in 
training that most businesses, as well as other models, 
reward people,” states Quinn Stabile. “With training, 
staff understood the use of incentives.”
First published in the Spring 2006 edition of the Dialogue
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Implementation of Evidence-Based 
Practices
Implementation of evidence-based practices in treatment settings is a key component of the effort to 
improve services in the addiction treatment field. The following article describes an actual project 
undertaken by the Danya Institute designed to implement and sustain the use of evidence-based 
practices in Baltimore city.
Project BOOST: A Science to Service Model
By Susan Swanton, LCSW-C
Ensuring that new competencies learned in training translate to the workplace is at the heart 
of the “science to service” effort.
In January 2003, the Danya Institute began the implementation of Project BOOST (Baltimore-
OSI Opportunities for Support through Training). This two-year project was funded by the 
Open Society Institute of Baltimore (OSI), and supported by the Baltimore Substance Abuse 
System, Inc. (BSAS), the funding and oversight agency for publicly funded substance abuse 
prevention and treatment services in Baltimore City. Project BOOST sought to improve the 
quality of care in the publicly funded substance abuse treatment system in Baltimore City 
through system-wide training and technical assistance to the 45 programs and 400 staff 
working in those programs.
Embracing principles of technology transfer, the project sought to enhance the competencies 
of staff at three levels of the organization: counselors, supervisors and program directors. 
Research has demonstrated that there are many factors that may facilitate or impede the 
application of new competencies learned by front line staff at training events. Some of these 
factors reside in the individual, some in the organization, and some in the larger treatment 
system. Given this, it is clear that effective and efficient transfer of skills, knowledge and 
attitudes acquired by front line staff take place in active partnership with supervisors and 
program directors. To affirm and nurture this partnership, Project BOOST was designed to 
provide training and support to counselors, supervisors and program directors.
This three-tiered approach was developed to foster the transfer of evidence-based practices 
by involving key staff positions at the beginning of the process. The staff members (program 
director, clinical supervisor, and counselors) greatly influence the adoption of “best practices” 
through their control over program policies, procedures and resources or through their direct 
responsibility for the implementation and maintenance of the new technology in daily 
practice. By involving them early in the process and educating them to the role they each 
play in technology transfer, it is hoped that resistance will be minimized and barriers to 
adoption can be identified early and addressed.
Counselor Support
Following guidelines suggested in the Addiction Technology Transfer Centers’ publication, 
The Change Book: A Blueprint for Technology Transfer (Center for Substance Abuse Treatment, 
2000), the project’s initial intervention was to identify treatment competencies that would 
enhance the skills of clinical staff and improve treatment. A needs assessment was conducted 
and, based on the responses, three training topics were chosen to provide a foundation in 
basic counseling skills. Each of these topics (“Establishing the Therapeutic Alliance,” “Group 
Counseling in Substance Abuse Treatment,” and “Practice Management in Substance Abuse 19
Published in 2000 by the ATTC 
Network through a cooperative 
agreement with SAMHSA/
CSAT, The Change Book: A 
Blueprint for Technology Transfer 
has become one of the most 
significant documents on the 
technology transfer and the 
initiation of change in 
substance abuse treatment 
and prevention settings. The 
Change Book is a tool to help 
organizations implement 
change initiatives that will 
improve prevention and 
treatment outcomes. The document is 
designed for administrators, staff, educators, and 
policy markers. The manual aims to increase the 
field’s knowledge about effec tive technology 
transfer methods and build organiza tional 
infrastructure for implementing change.
The Change Book can be ordered or down- 
loaded from the ATTC National office website 
at www.attcnetwork.org
Treatment” [this workshop was a combination of 
treatment planning, documentation and time 
management] was offered as a one-day workshop. 
Workshops were conducted by experienced 
trainers with reputations as experts in 
their fields, and used experiential and 
analytic learning formats to promote skill 
building among participants. Each 
workshop was offered a minimum of seven 
times each to allow all counselors to attend 
the workshop that would not seriously 
impact on the delivery of services at their 
program on any given day. These workshops 
were well received. The evaluations noted 
that 79 percent to 98 percent of the participants 
were either satisfied or very satisfied with the 
content of the training, the instructor, and the 
materials. After the training, 86 percent to 96 
percent of the participants responded that they 
strongly agreed that attending the workshops 
enhanced their skills and knowledge. The counselors 
cited that the most common problems to transferring 
the newly learned technology into daily practice were 
time, staff resources, agency policies and procedures, 
client needs, and the need for additional training.
During the second year of the project, the design called 
for training all counselors and supervisors in an 
evidenced-based, manual driven approach. To select 
the manual, the Project BOOST Advisory Committee 
was convened. This committee consisted of research 
experts in the fields of substance abuse training and 
technology transfer, representatives from the State of 
Maryland’s Office of Education and Training for 
Addiction Services (OETAS), a representative from 
Baltimore Substance Abuse Systems, Inc., and two 
representatives from the provider community. 
Available evidenced-based manuals were reviewed 
and two were identified for possible use in training. In 
order to ensure relevance, usefulness and program 
“buy-in,” a meeting of program directors and clinical 
directors/supervisors was held to make the final 
selection. The workshop was conducted using a 
modified version of the “Best Practices in Addiction 
Treatment” workshop that was being piloted by the 
National Addiction Technology Transfer Center. This 
approach asks participants to review and discuss the 
manuals in terms of their ease of application, potential 
barriers to implementation, and efficacy to the target 
population. At the conclusion of the workshop, the 
participants selected Volume 2 of the Project Match 
Monograph Series, Motivational Enhancement Therapy 
manual: A Clinical Research Guide for Therapist Treating 
Individuals with Alcohol Abuse and Dependence.
Clinical Supervisor Support
The role of the clinical supervisor is a key factor in the 
successful transfer of any new technology to the 
workplace. Ideally, the counselor’s day-to-day practice 
is monitored, evaluated and enhanced by the clinical 
supervisor and the clinical supervisor can reinforce 
newly acquired skills and practices. To that end, Project 
BOOST developed a program that concentrates on 
clinical supervision and the supervisor’s role in 
supporting and sustaining technology transfer.
Initially, all supervisors were invited to attend a three-
day workshop on clinical supervision sponsored by 
Project BOOST. Subsequent to this offering, OETAS 
agreed to offer their five-day, intermediate clinical 
supervision course at a very affordable rate. After the 
five-day course was completed, peer consultation 
groups began to meet. Participants were divided into 
groups by modalities. Seven groups were established, 
two for each modality of care (residential treatment, 
medication-assisted treatment, outpatient treatment), 
and one for adolescent treatment staff. Each group is 
held once a month for two hours. The frequency and 
The Change Book
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time frame was determined after input from participants who expressed 
both the desire for the groups and concern that attendance not put an 
undue burden on their already busy schedules.
Each month, a member presented a supervisee and discussed supervision 
issues and methods to improve their skills in supporting and developing 
their supervisee. On rare occasions, discussions were held on general 
clinical topics, but it is was felt that it is more useful to discuss issues as 
they are embodied in a staff person as this provides for concrete behavioral 
strategies and easy identification of the supervisor’s success in 
implementing new skills.
The overall philosophy of supervision being used in facilitating these 
groups is a view of supervision as primarily a relationship of trust and 
support that promotes learning though discussion, reflection and 
development of self-awareness for the purposes of developing, 
empowering, and supporting competent clinical practice and ensuring 
quality patient services. Within this context, groups are structured so as to 
maximize the learning opportunity through the sharing of best practices 
and improving skills used in developing counseling competencies in 
counselors. The goals of the groups were: to improve clinical supervision 
skills; to explore supervision methods that promote technology transfer; to 
facilitate an exchange of expertise and best practices among participants; 
and, to establish a cohesive, working peer consultation group that will 
continue after the grant has ended.
These groups have been met with overwhelming 
support. Participants were grateful for the opportunity 
to exchange ideas with peers and to improve their 
clinical skills. The eventually developed a cohesiveness 
that allowed for meaningful self-disclosure and 
feedback to each other. This, in turn, increased their 
self-awareness, their knowledge of theory, their 
relationship skills, and ability to support, develop, and 
empower their supervisees.
Program Director Support
Quarterly meetings over lunch were held to provide a 
forum for directors to: provide feedback and guidance 
concerning the progress of the project and its 
usefulness to their programs; discuss issues in 
technology transfer; and participate in guided 
discussions about leadership and management topics 
of interest to them. To ensure relevance, directors were 
asked which areas of non-profit management they 
would like to improve. Responses fell into three broad 
categories: personnel issues (staff recruitment and 
development, dealing with “difficult employees”), 
management issues (grant writing, use of technology to 
improve performance, long-term planning vs. crisis 
management), and leadership issues (strategic 
planning, building collaborative relationships with 
internal and external customers, developing and 
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managing non-profit boards). In seeking guest lecturers
for these luncheons, we moved outside of the traditional
addiction treatment trainers or leaders, and sought
resources from local universities and business. By doing
this, we hoped to expose program directors to an
expanded universe of technology from which they could
draw to improve the quality of their performance and 
meet the many challenges programs currently face in 
meeting the needs of their customers and stakeholders.
Three meetings were held. The first was used to 
introduce Project BOOST to the directors. The second 
meeting addressed the problem of integrating a 
program’s treatment philosophy into the daily practice 
of the staff through a discussion of the expectations of 
counselor competencies and performance evaluation. 
At the third meeting, the lecturer discussed operational 
tactics to achieve service priorities while juggling 
budgets and the concerns of funders, customers, 
boards, regulators and the community.
General Program Support
Technical Assistance: Another intervention used to 
ensure technology transfer is the provision of technical 
assistance to programs requesting assistance with 
specific issues in service provision. Meetings are 
conducted with the program and clinical director to 
develop an individual technical assistance plan that 
meets the needs of the program. Most of the technical 
assistance requested by the programs took the form 
of in-service trainings. The three most commonly 
requested topic areas are ethics, confidentiality, and 
treatment planning (problem lists, treatment plan, and 
documentation). Following these trainings, most 
programs requested additional assistance in improving 
the quality of their treatment plans and documentation. 
The second year of technical assistance focused on 
factors that are preventing or promoting the appli-
cation of the “best practice” to daily clinical practice.
Summary
Through shoring up basic clinical and supervisory skills,
and promoting the concepts of technology transfer and 
the role the counselor, supervisor and program director 
play in successful adoption of new technologies, the 
treatment system was primed to gain maximum benefit 
from the intensive training and supervision it will 
receive in an effort to implement a “best practice” in 
substance abuse treatment to improve the quality of 
care for the patients in Baltimore City.
Project BOOST has now ended. At the conclusion of 
Project BOOST, a comprehensive evaluation was done. 
This evaluation assessed the participants’ general 
satisfaction with the training and materials they 
received during Project BOOST. In addition to general 
satisfaction measures, the evaluation also conducted a 
pre- and post training comparison of client retention 
rates at the programs involved in the training. This was 
done to ascertain the extent to which the trainings may 
have affected client retention. The results of the 
evaluation indicated that most of the participants were 
extremely satisfied with the trainings and materials. 
Two-thirds of the participants also indicated that they 
acquired new skills which should be useful in their 
work. In terms of client retention, most client retention 
rates remained steady across all treatment modalities 
(Methadone Maintenance, Intensive Outpatient, 
Residential, Detoxification, Outpatient), however client 
retention rates for Outpatient services increased 
significantly for 30, 45, and 90 days or more. While 
these results are promising indicators of the impact of 
this training program, more investigation is needed to 
determine if these increases in client retention are 
related directly to the training program or if there are 
other factors involved.
First published in the June 2004 edition of the Dialogue
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Evidence-Based Practice Manuals 
and Web-Based Resources
National Implementation Research Network (NIRN)
The mission of the National Implementation Research Network (NIRN) is to close the gap 
between science and service by improving the science and practice of implementation in 
relation to evidence-based programs and practices.
  http://nirn.fmhi.usf.edu/aboutus/01_whatisnirn.cfm
Clinical Trials Network Dissemination Library
The CTN Dissemination Library is a digital repository of resources created by and about 
NIDA’s National Drug Abuse Treatment Clinical Trials Network (CTN). It provides CTN 
members and the public with a single point of access to research findings and other materials 
that are approved for dissemination throughout the CTN and to the larger community of 
providers, researchers and policymakers.
  http://ctndisseminationlibrary.org
The EBP Substance Abuse Database
The EBP Substance Abuse Database is one tool to help treatment providers make informed 
decisions about which science-based practices are most appropriate in which circumstances 
and for which individuals.
  www.adai.washington.edu/ebp
National Registry of Evidence-based Practices and Programs (NREPP)
The National Registry of Evidence-based Programs and Practices (NREPP), formerly the 
National Registry of Effective Programs, is a system designed to support informed decision 
making and to disseminate timely and reliable information about interventions that prevent 
and/or treat mental and substance use disorders. The NREPP system allows users to access 
descriptive information about interventions as well as peer-reviewed ratings of outcome-
specific evidence across several dimensions.
  www.nrepp.samhsa.gov
Southern Coast Beacon: Evidence-based Practices
First article of a three-part series on evidence-based practices (Developed by the Southern 
Coast ATTC).
  www.scattc.org/pdf_upload/Beacon001.pdf#search=%22evidence-based%20practices 
  %20in%20addiction%22
Implementing Change in Substance Abuse Treatment Programs: Treatment
Assistance Publication 31 (TAP 31)
Manual offers guidance on how to integrate evidence-based practices (EBPs) for substance 
abuse treatment into clinical practice. Informed by the realities of many substance abuse 
treatment providers, it suggests efficient solutions for implementing change based on 
proven methods.
  http://download.ncadi.samhsa.gov/prevline/pdfs/SMA09-4377.pdf
Turning Knowledge into Practice
A manual for behavioral health administrators and practitioners about understanding and 
implementing evidence-based practices.
  www.tacinc.org/Docs/HS/EBPmanual.pdf
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